167 related articles for article (PubMed ID: 37735489)
1. Imidazo[1,2-c]quinazolines as a novel and potent scaffold of α-glucosidase inhibitors: design, synthesis, biological evaluations, and in silico studies.
Peytam F; Hosseini FS; Hekmati M; Bayati B; Moghadam MS; Emamgholipour Z; Firoozpour L; Mojtabavi S; Faramarzi MA; Sadat-Ebrahimi SE; Tehrani MB; Foroumadi A
Sci Rep; 2023 Sep; 13(1):15672. PubMed ID: 37735489
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, in vitro, and in silico enzymatic evaluations of thieno[2,3-b]quinoline-hydrazones as novel inhibitors for α-glucosidase.
Noori M; Rastak M; Halimi M; Ghomi MK; Mollazadeh M; Mohammadi-Khanaposhtani M; Sayahi MH; Rezaei Z; Mojtabavi S; Ali Faramarzi M; Larijani B; Biglar M; Amanlou M; Mahdavi M
Bioorg Chem; 2022 Oct; 127():105996. PubMed ID: 35878449
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
Gong Z; Xie Z; Qiu J; Wang G
Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
[TBL] [Abstract][Full Text] [Related]
4. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
5. Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study.
Abuelizz HA; Anouar EH; Ahmad R; Azman NIIN; Marzouk M; Al-Salahi R
PLoS One; 2019; 14(8):e0220379. PubMed ID: 31412050
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase.
Peytam F; Takalloobanafshi G; Saadattalab T; Norouzbahari M; Emamgholipour Z; Moghimi S; Firoozpour L; Bijanzadeh HR; Faramarzi MA; Mojtabavi S; Rashidi-Ranjbar P; Karima S; Pakraad R; Foroumadi A
Sci Rep; 2021 Jun; 11(1):11911. PubMed ID: 34099819
[TBL] [Abstract][Full Text] [Related]
7. Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies.
Farzaneh E; Mohammadi M; Raymand P; Noori M; Golestani S; Ranjbar S; Ghasemi Y; Mohammadi-Khanaposhtani M; Asadi M; Nasli Esfahani E; Rastegar H; Larijani B; Mahdavi M; Taslimi P
Bioorg Chem; 2024 Apr; 145():107207. PubMed ID: 38402795
[TBL] [Abstract][Full Text] [Related]
8. Aryl-quinoline-4-carbonyl hydrazone bearing different 2-methoxyphenoxyacetamides as potent α-glucosidase inhibitors; molecular dynamics, kinetic and structure-activity relationship studies.
Hamedifar H; Mirfattahi M; Khalili Ghomi M; Azizian H; Iraji A; Noori M; Moazzam A; Dastyafteh N; Nokhbehzaim A; Mehrpour K; Javanshir S; Mojtabavi S; Faramarzi MA; Larijani B; Hajimiri MH; Mahdavi M
Sci Rep; 2024 Jan; 14(1):388. PubMed ID: 38172167
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
[TBL] [Abstract][Full Text] [Related]
10. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
[TBL] [Abstract][Full Text] [Related]
11. New cycloalkyl[b]thiophenylnicotinamide-based α-glucosidase inhibitors as promising anti-diabetic agents: Synthesis, in silico study, in vitro and in vivo evaluations.
Wang KM; Ge YX; Zhang J; Chen YT; Zhang NY; Gu JS; Fang L; Zhang XL; Zhang J; Jiang CS
Bioorg Med Chem Lett; 2023 Jan; 79():129069. PubMed ID: 36395995
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Amide-Functionalized Benzimidazolium Salts as Potent α-Glucosidase Inhibitors.
Khan IA; Ahmad M; Ashfaq UA; Sultan S; Zaki MEA
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443347
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, in vitro anti-α-glucosidase evaluations, and computational studies of new phthalimide-phenoxy-1,2,3-triazole-N-phenyl (or benzyl) acetamides as potential anti-diabetic agents.
Emadi M; Halimi M; Moazzam A; Hosseini S; Mojtabavi S; Faramarzi MA; Ghadimi R; Moghadamnia AA; Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Mahdavi M
Sci Rep; 2023 Jun; 13(1):10030. PubMed ID: 37340010
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
Wang G; Chen M; Qiu J; Xie Z; Cao A
Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of α-glucosidase.
Rahim F; Ullah H; Javid MT; Wadood A; Taha M; Ashraf M; Shaukat A; Junaid M; Hussain S; Rehman W; Mehmood R; Sajid M; Khan MN; Khan KM
Bioorg Chem; 2015 Oct; 62():15-21. PubMed ID: 26162519
[TBL] [Abstract][Full Text] [Related]
16. Novel pyridine-2,4,6-tricarbohydrazide thiourea compounds as small key organic molecules for the potential treatment of type-2 diabetes mellitus: In vitro studies against yeast α- and β-glucosidase and in silico molecular modeling.
Rehman TU; Riaz S; Khan IU; Ashraf M; Bajda M; Gawalska A; Yar M
Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29194730
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and α-glucosidase inhibition studies of norfloxacin-acetanilide hybrids.
Walayat K; Ahmad M; Ali Ashfaq U; Ali Khan Z; Sultan S
Pak J Pharm Sci; 2021 Sep; 34(5(Supplementary)):1909-1915. PubMed ID: 34836859
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Insights into the Inhibitory Activities of Chemical Constituents from the Fruits of Terminalia boivinii on α-Glucosidase.
Dlamini BS; Chen CR; Chen YK; Hsu JL; Shih WL; Chang CI
Chem Biodivers; 2022 Jul; 19(7):e202200137. PubMed ID: 35726787
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
Azimi F; Ghasemi JB; Azizian H; Najafi M; Faramarzi MA; Saghaei L; Sadeghi-Aliabadi H; Larijani B; Hassanzadeh F; Mahdavi M
Int J Biol Macromol; 2021 Jan; 166():1082-1095. PubMed ID: 33157144
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.
Saeedi M; Mohammadi-Khanaposhtani M; Asgari MS; Eghbalnejad N; Imanparast S; Faramarzi MA; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Med Chem; 2019 Dec; 27(23):115148. PubMed ID: 31679980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]